Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jim Julian

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
BMJ (Clinical Research Ed.)|May 26, 2011
Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trialsFlorent Boutitie, Laurent Pinede, Sam Schulman, et al.
Archives of Pathology & Laboratory Medicine|January 10, 2008
HER2 testing in a population-based study of patients with metastatic breast cancer treated with trastuzumabFrances P O'Malley, Tom Thomson, Jim Julian, et al.
Journal of the American Society of Nephrology : JASN|August 23, 2002
Low-intensity warfarin is ineffective for the prevention of PTFE graft failure in patients on hemodialysis: a randomized controlled trialMark A Crowther, Catherine M Clase, Peter J Margetts, et al.
International Journal of Radiation Oncology, Biology, Physics|April 26, 2020
Acute Toxicity and Quality of Life of Hypofractionated Radiation Therapy for Breast CancerJulie Arsenault, Sameer Parpia, Mira Goldberg, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 21, 2013
Targeted gene sequencing identifies variants in the protein C and endothelial protein C receptor genes in patients with unprovoked venous thromboembolismCynthia Wu, Dhruva J Dwivedi, Laura Pepler, et al.
Journal of the National Cancer Institute|April 17, 2003
Helping patients make informed choices: a randomized trial of a decision aid for adjuvant chemotherapy in lymph node-negative breast cancerTimothy Whelan, Carol Sawka, Mark Levine, et al.
Journal of the National Cancer Institute|August 8, 2002
Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancerTimothy Whelan, Robert MacKenzie, Jim Julian, et al.
American Heart Journal|March 30, 2013
Rationale and design of the ATTRACT Study: a multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosisSuresh Vedantham, Samuel Z Goldhaber, Susan R Kahn, et al.
The New England Journal of Medicine|September 19, 2003
A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndromeMark A Crowther, Jeff S Ginsberg, Jim Julian, et al.
Annals of Internal Medicine|January 16, 2013
Selective D-dimer testing for diagnosis of a first suspected episode of deep venous thrombosis: a randomized trialLori-Ann Linkins, Shannon M Bates, Eddy Lang, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
BMJ (Clinical Research Ed.)|May 26, 2011
Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trialsFlorent Boutitie, Laurent Pinede, Sam Schulman, et al.
Archives of Pathology & Laboratory Medicine|January 10, 2008
HER2 testing in a population-based study of patients with metastatic breast cancer treated with trastuzumabFrances P O'Malley, Tom Thomson, Jim Julian, et al.
Journal of the American Society of Nephrology : JASN|August 23, 2002
Low-intensity warfarin is ineffective for the prevention of PTFE graft failure in patients on hemodialysis: a randomized controlled trialMark A Crowther, Catherine M Clase, Peter J Margetts, et al.
International Journal of Radiation Oncology, Biology, Physics|April 26, 2020
Acute Toxicity and Quality of Life of Hypofractionated Radiation Therapy for Breast CancerJulie Arsenault, Sameer Parpia, Mira Goldberg, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 21, 2013
Targeted gene sequencing identifies variants in the protein C and endothelial protein C receptor genes in patients with unprovoked venous thromboembolismCynthia Wu, Dhruva J Dwivedi, Laura Pepler, et al.
Journal of the National Cancer Institute|April 17, 2003
Helping patients make informed choices: a randomized trial of a decision aid for adjuvant chemotherapy in lymph node-negative breast cancerTimothy Whelan, Carol Sawka, Mark Levine, et al.
Journal of the National Cancer Institute|August 8, 2002
Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancerTimothy Whelan, Robert MacKenzie, Jim Julian, et al.
American Heart Journal|March 30, 2013
Rationale and design of the ATTRACT Study: a multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosisSuresh Vedantham, Samuel Z Goldhaber, Susan R Kahn, et al.
The New England Journal of Medicine|September 19, 2003
A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndromeMark A Crowther, Jeff S Ginsberg, Jim Julian, et al.
Annals of Internal Medicine|January 16, 2013
Selective D-dimer testing for diagnosis of a first suspected episode of deep venous thrombosis: a randomized trialLori-Ann Linkins, Shannon M Bates, Eddy Lang, et al.
Pageof 3